A novel design of a scale-up nanoporous membrane centrifuge (see Figure 1 (a), (b), (c), and (d)) is proposed for reverse osmosis desalination, and the proof of concept is demonstrated through large scale molecular dynamics simulations reported in this article.
Welsh scientists piecing together the giant jigsaw puzzle of plant pollination are a step closer to knowing how it all fits thanks to a new paper by Swansea University Ph.D. researcher Andrew Lucas.
The Collaborative Laboratories for Environmental Analysis and Remediation at the University of Texas at Arlington has expanded its partnership with oil field equipment supplier Challenger Water Solutions to develop water recycling technologies that will transform waste from unconventional oil and gas development into reusable water.
Thanks to a new method of analyzing ultrasound images, conventional scanners can be used for generating high-res images of blood vessels in tumors. This approach makes it easier to distinguish between different types of tumors, and it facilitates the tracking of the progress and success of chemotherapy.
Yaling Liu, of Lehigh University, has created an innovative microfluidic device that uses magnetic particles and wavy-herringbone design to capture and release circulating tumor cells with an 80-95% capture efficiency rate at different tumor cell concentrations. Liu will present some of his findings today, April 18th, at a conference taking place in Istanbul, Turkey called The Future of Medicine hosted by Royal Academy of Science International Trust (RASIT) and Bahçe?ehir University.
ETH researchers working with Martin Fussenegger have developed an early warning system for the four most common types of cancer. Should a tumor develop, a visible mole will appear on the skin.
A Vanderbilt team and their international colleagues characterized for the first time a complex, little-understood cellular receptor type that, when activated, shuts off hunger.
Despite the great successes of targeted cancer drugs and the promise of novel immunotherapies, the vast majority of people diagnosed with cancer are still first treated with chemotherapy. Now a new study by UCSF researchers using techniques drawn from computational biology could make it much easier for physicians to use the genetic profile of a patient's tumor to pick the chemotherapy treatment with the fewest side effects and best chance of success.
A blood test to measure the levels of two proteins in plasma that are common predictors of lung cancer was 98 percent effective in a multicenter clinical trial at distinguishing benign from malignant lung nodules when combined with a patient's clinical characteristics to form an integrated classifier. These results were reported by a team of investigators at the Medical University of South Carolina in an article in Chest.
Practically all biochemical processes involve enzymes that accelerate chemical reactions. A research team from the Technical University of Munich (TUM) has now for the first time deciphered the molecular mechanism of the enzyme AsqJ. Their findings might open up new options in the production of pharmaceutically active molecules.